Literature DB >> 17415644

Chronic hypergastrinemia: causes and consequences.

Lori A Orlando1, Lane Lenard, Roy C Orlando.   

Abstract

The hormone gastrin plays 2 important roles in gastrointestinal physiology--1 as a major factor in meal-stimulated gastric acid secretion and the other as a trophic hormone for epithelial and enterochromaffin cells. These roles are exaggerated to the point of pathology under conditions of chronic hypergastrinemia as exemplified by the Zollinger-Ellison syndrome and pernicious anemia. More recently, the concern about the potential risk of chronic hypergastrinemia has risen because of the widespread use of proton pump inhibitors for maintenance therapy in reflux esophagitis. For this reason, we present a concise overview of the origin, causes, and potential risks of chronic hypergastrinemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17415644     DOI: 10.1007/s10620-006-9419-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  71 in total

Review 1.  Results of short-and long-term medical treatment of gastroesophageal reflux disease (GERD).

Authors:  T Pohle; W Domschke
Journal:  Langenbecks Arch Surg       Date:  2000-08       Impact factor: 3.445

2.  Biosynthesis of gastrin. Localization of the precursor and peptide products using electron microscopic-immunogold methods.

Authors:  J Rahier; S Pauwels; G J Dockray
Journal:  Gastroenterology       Date:  1987-05       Impact factor: 22.682

3.  Gastrin and colorectal cancer. Evidence against an association.

Authors:  R Yapp; I M Modlin; R R Kumar; H J Binder; R Dubrow
Journal:  Dig Dis Sci       Date:  1992-04       Impact factor: 3.199

4.  Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis.

Authors:  S A Watson; A M Smith
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

Review 5.  Pernicious anemia and gastric carcinoid tumor: case report and review.

Authors:  D Sculco; S Bilgrami
Journal:  Am J Gastroenterol       Date:  1997-08       Impact factor: 10.864

6.  Expression, processing, and secretion of gastrin in patients with colorectal carcinoma.

Authors:  G D Ciccotosto; A McLeish; K J Hardy; A Shulkes
Journal:  Gastroenterology       Date:  1995-10       Impact factor: 22.682

7.  Gastric carcinoids. An immunohistochemical and clinicopathologic study of 104 patients.

Authors:  R M Thomas; J H Baybick; A M Elsayed; L H Sobin
Journal:  Cancer       Date:  1994-04-15       Impact factor: 6.860

8.  Pharmacology and toxicology of omeprazole--with special reference to the effects on the gastric mucosa.

Authors:  E Carlsson; H Larsson; H Mattsson; B Ryberg; G Sundell
Journal:  Scand J Gastroenterol Suppl       Date:  1986

9.  Gastrin and colorectal cancer: a prospective study.

Authors:  C M Thorburn; G D Friedman; C J Dickinson; J H Vogelman; N Orentreich; J Parsonnet
Journal:  Gastroenterology       Date:  1998-08       Impact factor: 22.682

10.  Prolonged hypergastrinemia does not increase the frequency of colonic neoplasia in patients with Zollinger-Ellison syndrome.

Authors:  M Orbuch; D J Venzon; I A Lubensky; H C Weber; F Gibril; R T Jensen
Journal:  Dig Dis Sci       Date:  1996-03       Impact factor: 3.199

View more
  22 in total

1.  Hypergastrinemia--diagnosis and treatment.

Authors:  Bruno Niederle
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

Review 2.  Classification of anemia for gastroenterologists.

Authors:  Jose Antonio Moreno Chulilla; Maria Soledad Romero Colás; Martín Gutiérrez Martín
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

3.  A network map of the gastrin signaling pathway.

Authors:  Yashwanth Subbannayya; Kumari Anuja; Jayshree Advani; Urmesh Kumar Ojha; Vishalakshi Nanjappa; Bijesh George; Avinash Sonawane; Rekha V Kumar; Girija Ramaswamy; Akhilesh Pandey; B L Somani; Rajesh Raju
Journal:  J Cell Commun Signal       Date:  2014-03-02       Impact factor: 5.782

4.  Serum gastrin and cholecystokinin are associated with subsequent development of gastric cancer in a prospective cohort of Finnish smokers.

Authors:  Gwen Murphy; Christian C Abnet; Hyoyoung Choo-Wosoba; Emily Vogtmann; Stephanie J Weinstein; Philip R Taylor; Satu Männistö; Demetrius Albanes; Sanford M Dawsey; Jens F Rehfeld; Neal D Freedman
Journal:  Int J Epidemiol       Date:  2017-06-01       Impact factor: 7.196

5.  Acid peptic diseases: pharmacological approach to treatment.

Authors:  Alex Mejia; Walter K Kraft
Journal:  Expert Rev Clin Pharmacol       Date:  2009-05       Impact factor: 5.045

6.  Protective effects of D-002 on experimentally induced gastroesophageal reflux in rats.

Authors:  Zullyt Zamora; Vivian Molina; Rosa Mas; Yazmin Ravelo; Yohany Perez; Ambar Oyarzabal
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

7.  Regulated expression of the human gastrin gene in mice.

Authors:  Edith Mensah-Osman; Ed Labut; Yana Zavros; Mohamad El-Zaatari; David J Law; Juanita L Merchant
Journal:  Regul Pept       Date:  2008-03-28

Review 8.  Gastrin, inflammation, and carcinogenesis.

Authors:  Celia Chao; Mark R Hellmich
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-02       Impact factor: 3.243

9.  Diagnosis of pernicious anemia and the risk of pancreatic cancer.

Authors:  Pari Shah; Andrew D Rhim; Kevin Haynes; Wei-Ting Hwang; Yu-Xiao Yang
Journal:  Pancreas       Date:  2014-04       Impact factor: 3.327

Review 10.  Long-term proton pump inhibitor use and gastrointestinal cancer.

Authors:  David Y Graham; Robert M Genta
Journal:  Curr Gastroenterol Rep       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.